{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:17:11Z","timestamp":1792873031661,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03631-0","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T05:02:12Z","timestamp":1702443732000},"page":"757-762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Renal Dysfunction in Primary Hyperparathyroidism is associated with nephrolithiasis, elevated serum calcium-phosphate product and parathormone levels"],"prefix":"10.1007","volume":"83","author":[{"given":"Mainak","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Ahamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhritiman","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Maisnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapas Chandra","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranab Kumar","family":"Sahana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhankar","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8033-5748","authenticated-orcid":false,"given":"Satinath","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"key":"3631_CR1","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jbmr.4677","volume":"37","author":"JP Bilezikian","year":"2022","unstructured":"J.P. Bilezikian, A.A. Khan, S.J. Silverberg et al. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J. Bone Mineral Res. 37, 2293\u20132314 (2022). https:\/\/doi.org\/10.1002\/jbmr.4677","journal-title":"J. Bone Mineral Res."},{"key":"3631_CR2","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S2213-8587(16)00076-0","volume":"4","author":"S Minisola","year":"2016","unstructured":"S. Minisola, J. Pepe, A. Scillitani, C. Cipriani, Explaining geographical variation in the presentation of primary hyperparathyroidism. Lancet Diab. Endocrinol. 4, 641\u2013643 (2016). https:\/\/doi.org\/10.1016\/S2213-8587(16)00076-0","journal-title":"Lancet Diab. Endocrinol."},{"key":"3631_CR3","doi-asserted-by":"publisher","unstructured":"N. Yu, P.T. Donnan, R.W. Flynn, et al. (2009) Increased mortality and morbidity in mild primary hyperparathyroid patients. Clin. Endocrinol. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03766.x","DOI":"10.1111\/j.1365-2265.2009.03766.x"},{"key":"3631_CR4","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1210\/jc.2018-00923","volume":"103","author":"H Ejlsmark-Svensson","year":"2018","unstructured":"H. Ejlsmark-Svensson, L.S. Bislev, L. Rolighed et al. Predictors of renal function and calcifications in primary hyperparathyroidism: a nested case-control study. J. Clin. Endocrinol. Metab. 103, 3574\u20133583 (2018). https:\/\/doi.org\/10.1210\/jc.2018-00923","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3631_CR5","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1210\/jc.2009-0587","volume":"94","author":"F Tassone","year":"2009","unstructured":"F. Tassone, L. Gianotti, I. Emmolo et al. Glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 94, 4458\u20134461 (2009). https:\/\/doi.org\/10.1210\/jc.2009-0587","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3631_CR6","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1210\/jc.2013-4192","volume":"99","author":"MD Walker","year":"2014","unstructured":"M.D. Walker, T. Nickolas, A. Kepley et al. Predictors of renal function in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 99, 1885\u20131892 (2014). https:\/\/doi.org\/10.1210\/jc.2013-4192","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3631_CR7","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1210\/jc.2014-1379","volume":"99","author":"CD Hendrickson","year":"2014","unstructured":"C.D. Hendrickson, D.J. Castro Pereira, R.J. Comi, Renal impairment as a surgical indication in primary hyperparathyroidism: do the data support this recommendation? J Clin Endocrinol Metab 99, 2646\u20132650 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1379","journal-title":"J Clin Endocrinol Metab"},{"key":"3631_CR8","doi-asserted-by":"publisher","unstructured":"Yamashita H., Noguchi S., Uchino S., et al (2003) Influence of renal function on clinico-pathological features of primary hyperparathyroidism. Eur. J. Endocrinol. 597\u2013602 https:\/\/doi.org\/10.1530\/eje.0.1480597","DOI":"10.1530\/eje.0.1480597"},{"key":"3631_CR9","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"A.S. Levey, L.A. Stevens, C.H. Schmid et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604 (2009). https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann. Intern. Med."},{"key":"3631_CR10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"P.E. Stevens, Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann. Intern. Med. 158, 825 (2013). https:\/\/doi.org\/10.7326\/0003-4819-158-11-201306040-00007","journal-title":"Ann. Intern. Med."},{"key":"3631_CR11","doi-asserted-by":"publisher","first-page":"e0229345","DOI":"10.1371\/journal.pone.0229345","volume":"15","author":"DG Jenkins","year":"2020","unstructured":"D.G. Jenkins, P.F. Quintana-Ascencio, A solution to minimum sample size for regressions. PLoS ONE 15, e0229345 (2020). https:\/\/doi.org\/10.1371\/journal.pone.0229345","journal-title":"PLoS ONE"},{"key":"3631_CR12","doi-asserted-by":"crossref","unstructured":"B.L Clarke (2019) Asymptomatic primary hyperparathyroidism. In: Brandi M.L. (ed) Frontiers of Hormone Research. S. Karger AG, pp 13\u201322","DOI":"10.1159\/000491035"},{"key":"3631_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/medicina58030420","volume":"58","author":"M Medina-Escobedo","year":"2022","unstructured":"M. Medina-Escobedo, K. S\u00e1nchez-Pozos, A.L. Guti\u00e9rrez-Solis et al. Recurrence of nephrolithiasis and surgical events are associated with chronic kidney disease in adult patients. Medicina 58, 420 (2022). https:\/\/doi.org\/10.3390\/medicina58030420","journal-title":"Medicina"},{"key":"3631_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12882-020-01950-2","volume":"21","author":"T-F Chuang","year":"2020","unstructured":"T.-F. Chuang, H.-C. Hung, S.-F. Li et al. Risk of chronic kidney disease in patients with kidney stones\u2014a nationwide cohort study. BMC Nephrol. 21, 292 (2020). https:\/\/doi.org\/10.1186\/s12882-020-01950-2","journal-title":"BMC Nephrol."},{"key":"3631_CR15","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1210\/jc.2006-0070","volume":"91","author":"L Gianotti","year":"2006","unstructured":"L. Gianotti, F. Tassone, F. Cesario et al. A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 91, 3011\u20133016 (2006). https:\/\/doi.org\/10.1210\/jc.2006-0070","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3631_CR16","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1210\/jc.2011-3072","volume":"97","author":"MD Walker","year":"2012","unstructured":"M.D. Walker, D.W. Dempster, D.J. McMahon et al. Effect of renal function on skeletal health in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 97, 1501\u20131507 (2012). https:\/\/doi.org\/10.1210\/jc.2011-3072","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3631_CR17","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","volume":"32","author":"S Minisola","year":"2018","unstructured":"S. Minisola, L. Gianotti, S. Bhadada, S.J. Silverberg, Classical complications of primary hyperparathyroidism. Best Pract. Res. Clin. Endocrinol. Metab. 32, 791\u2013803 (2018). https:\/\/doi.org\/10.1016\/j.beem.2018.09.001","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"3631_CR18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.21037\/tau-22-366","volume":"11","author":"C Wang","year":"2022","unstructured":"C. Wang, S. Wu, J. Li et al. Bioinformatics analysis of the potential regulatory mechanisms of renal fibrosis and the screening and identification of factors related to human renal fibrosis. Transl. Androl. Urol. 11, 859\u2013866 (2022). https:\/\/doi.org\/10.21037\/tau-22-366","journal-title":"Transl. Androl. Urol."},{"key":"3631_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s43162-021-00067-8","volume":"33","author":"NA Bhat","year":"2021","unstructured":"N.A. Bhat, F. Mustafa, R.Y. Sheikh, I. Wani, Incidence, etiology, and course of hypercalcemia-induced AKI in a tertiary care center from northern India. Egypt J. Intern. Med. 33, 36 (2021). https:\/\/doi.org\/10.1186\/s43162-021-00067-8","journal-title":"Egypt J. Intern. Med."},{"key":"3631_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/21548331.2019.1568719","volume":"47","author":"C Thongprayoon","year":"2019","unstructured":"C. Thongprayoon, W. Cheungpasitporn, M.A. Mao et al. Elevated admission serum calcium phosphate product as an independent risk factor for acute kidney injury in hospitalized patients. Hosp. Pract. 47, 73\u201379 (2019). https:\/\/doi.org\/10.1080\/21548331.2019.1568719","journal-title":"Hosp. Pract."},{"key":"3631_CR21","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1089\/end.2020.0403","volume":"34","author":"W Sui","year":"2020","unstructured":"W. Sui, J.K. Calvert, N.L. Kavoussi et al. Association of chronic kidney disease stage with 24-hour urine values among patients with nephrolithiasis. J. Endourol. 34, 1263\u20131271 (2020). https:\/\/doi.org\/10.1089\/end.2020.0403","journal-title":"J. Endourol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03631-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03631-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03631-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T02:17:01Z","timestamp":1709173021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03631-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["3631"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03631-0","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"27 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written consent was obtained from every study participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was approved by institutional ethics committee. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}